BESREMI
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BESREMI, covering 2021-11-12 to 2026-04-24. Get the full timeline:
Most recent: EMA Authorised: Besremi (ropeginterferon alfa-2b) — AOP Orphan Pharmaceuticals GmbH